skip to content

eLesor Investments version="1.1" id="Layer_1" xmlns="" xmlns:xlink="" x="0px" y="0px" viewBox="0 0 697.5 99.8" style="enable-background:new 0 0 697.5 99.8;" xml:space="preserve" aria-labelledby="title--mwlogoHeader desc--mwlogoHeader" role="img"> eLesor Site Logo A link that brings you back to the homepage.

Company Close Updates

Vertex Pharmaceuticals Inc. stock falls Thursday, underperforms market

Company Logo

Terrence Horan

Referenced Symbols

Shares of Vertex Pharmaceuticals Inc. VRTX, +0.60% slipped 0.13% to $196.02 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, -0.54% rising 0.20% to 4,367.48 and the Dow Jones Industrial Average DJIA, -0.42% rising 0.07% to 34,823.35. This was the stock's fourth consecutive day of losses. Vertex Pharmaceuticals Inc. closed $95.97 below its 52-week high ($291.99), which the company achieved on July 23rd.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson JNJ, +0.01% rose 0.29% to $169.98, Merck & Co. Inc. MRK, -0.08% rose 0.18% to $76.53, and AbbVie Inc. ABBV, -2.16% rose 0.47% to $117.54. Trading volume (1.3 M) remained 1.1 million below its 50-day average volume of 2.4 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Partner Center